Envista Holdings Corp NVST NYSE

NYSE • Healthcare • Medical - Equipment & Services • US • USD

SharesGrow Score

45/100

0/7 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Envista Holdings Corp (NVST), 包括 36 笔买入 和 11 笔卖出. 内部人买入总额为 $7.05M 内部人卖出总额为 $3.39M.

近期活跃的重要内部人包括 Hammes Eric D., Keel Paul A, Nance Mark E. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — NVST

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2026-02-25	Hammes Eric D.	Chief Financial Officer	限制性股票授予 (RSU)	29,225	-	-	29,225
2026-02-25	Keel Paul A	Chief Executive Officer	限制性股票授予 (RSU)	115,320	$29.59	$3.41M	115,320
2026-02-25	Nance Mark E	General Counsel	限制性股票授予 (RSU)	23,070	-	-	23,070
2026-02-25	Reis Mischa	SVP, Strategy & Bus. Dev.	限制性股票授予 (RSU)	10,770	-	-	10,770
2026-02-25	Kaabi Faez C	Chief Accounting Officer	RSU 预扣税	4,964	$29.59	$146.88K	45,032
2026-02-25	Befidi Robert	President, Diagnostics	限制性股票授予 (RSU)	13,845	-	-	13,845
2026-02-25	Nilsson Stefan	President, Nobel Biocare	限制性股票授予 (RSU)	13,845	-	-	13,845
2026-02-25	Acurio Veronica	President, Orthodontics	限制性股票授予 (RSU)	13,845	-	-	13,845
2026-02-10	Reis Mischa	SVP, Strategy & Bus. Dev.	期权行权（卖出）	5,634	$15.97	$89.97K	-
2026-02-01	Hammes Eric D.	Chief Financial Officer	限制性股票授予 (RSU)	1,119	-	-	1,119
2026-02-01	Keel Paul A	Chief Executive Officer	限制性股票授予 (RSU)	4,091	-	-	4,091
2026-02-01	Nance Mark E	General Counsel	限制性股票授予 (RSU)	2,006	-	-	7,587
2026-02-01	Reis Mischa	SVP, Strategy & Bus. Dev.	限制性股票授予 (RSU)	2,919	-	-	29,357
2026-02-01	Kaabi Faez C	Chief Accounting Officer	限制性股票授予 (RSU)	1,186	-	-	5,040
2026-02-01	Befidi Robert	President, Diagnostics	限制性股票授予 (RSU)	998	-	-	2,149
2026-02-01	Acurio Veronica	President, Orthodontics	限制性股票授予 (RSU)	998	-	-	998
2025-11-01	Keel Paul A	Chief Executive Officer	RSU 预扣税	54,097	$20.35	$1.1M	347,555
2025-08-25	Hammes Eric D.	Chief Financial Officer	RSU 预扣税	7,654	$21.12	$161.65K	96,788
2025-08-25	Reis Mischa	SVP, Strategy & Bus. Dev.	知情卖出	15,000	$21.60	$324K	32,382
2025-08-25	Befidi Robert	President, Diagnostics	RSU 预扣税	3,454	$21.12	$72.95K	45,504
2025-08-25	Nilsson Stefan	President, Nobel Biocare	RSU 预扣税	804	$21.12	$16.98K	54,941
2025-08-25	Acurio Veronica	President, Orthodontics	RSU 预扣税	5,422	$21.12	$114.51K	50,323
2025-07-14	Pierce James Andrew	Director	未知	-	-	-	-
2025-07-14	Pierce James Andrew	Director	限制性股票授予 (RSU)	9,155	-	-	9,155
2025-06-10	Tsingos Christine A	Director	限制性股票授予 (RSU)	10,450	-	-	50,600
2025-06-10	Raskas Daniel	Director	限制性股票授予 (RSU)	10,450	-	-	44,680
2025-06-10	Gallahue Kieran	Director	限制性股票授予 (RSU)	10,450	-	-	44,680
2025-06-10	Huennekens R Scott	Director	限制性股票授予 (RSU)	14,370	-	-	69,520
2025-06-10	Jain Vivek	Director	限制性股票授予 (RSU)	10,450	-	-	43,615
2025-06-10	Carruthers Wendy	Director	限制性股票授予 (RSU)	10,450	-	-	50,610
2025-06-10	Hulit Barbara B.	Director	限制性股票授予 (RSU)	10,450	-	-	79,820
2025-05-25	Keel Paul A	Chief Executive Officer	RSU 预扣税	12,787	$16.72	$213.8K	401,652
2025-02-26	Reis Mischa	SVP, Strategy & Bus. Dev.	限制性股票授予 (RSU)	8,475	-	-	47,382
2025-02-25	Hammes Eric D.	Chief Financial Officer	限制性股票授予 (RSU)	28,995	-	-	28,995
2025-02-25	Keel Paul A	Chief Executive Officer	限制性股票授予 (RSU)	153,660	$20.66	$3.17M	153,660
2025-02-25	Nance Mark E	General Counsel	限制性股票授予 (RSU)	33,455	-	-	33,455
2025-02-25	Reis Mischa	SVP, Strategy & Bus. Dev.	限制性股票授予 (RSU)	15,615	-	-	15,615
2025-02-25	Kaabi Faez C	Chief Accounting Officer	限制性股票授予 (RSU)	22,600	$20.66	$466.92K	22,600
2025-02-25	Befidi Robert	President, Diagnostics	限制性股票授予 (RSU)	18,960	-	-	18,960
2025-02-25	Nilsson Stefan	President, Nobel Biocare	限制性股票授予 (RSU)	18,960	-	-	18,960
2025-02-25	Acurio Veronica	President, Orthodontics	限制性股票授予 (RSU)	18,960	-	-	18,960
2025-02-01	Nance Mark E	General Counsel	限制性股票授予 (RSU)	965	-	-	5,581
2025-02-01	Reis Mischa	SVP, Strategy & Bus. Dev.	限制性股票授予 (RSU)	3,152	-	-	26,438
2025-02-01	Kaabi Faez C	Chief Accounting Officer	限制性股票授予 (RSU)	689	-	-	3,854
2025-02-01	Befidi Robert	President, Diagnostics	限制性股票授予 (RSU)	1,151	-	-	1,151
2024-11-18	Nilsson Stefan	President, Nobel Biocare	未知	-	-	-	45,455
2024-11-18	Acurio Veronica	President, Orthodontics	未知	-	-	-	45,455
2024-11-01	Keel Paul A	Chief Executive Officer	RSU 预扣税	53,996	$20.94	$1.13M	348,609
2024-09-17	Reis Mischa	SVP, Strategy & Bus. Dev.	RSU 预扣税	812	$19.00	$15.43K	42,720
2024-08-25	Hammes Eric D.	Chief Financial Officer	限制性股票授予 (RSU)	64,175	-	-	88,707